Political Squabbles Slow Drug Development for Rare Diseases
Political conflicts have stagnated the FDA's attempts to modernize clinical trials to effectively reflect the global population. Research for rare disease treatments lacks racial and ethnic...(PRWeb September 06, 2022)Read the full story at https://www.prweb.com/releases/political_squabbles_slow_drug_development_for_rare_diseases/prweb18879956.htm
Source: PRWeb: Medical Pharmaceuticals - Category: Pharmaceuticals Source Type: news